Paragon Bioservices, Inc.
Orlando Lopez is currently serving as the Manager of Downstream Manufacturing at Paragon Bioservices, Inc. Prior to this, Orlando held positions such as Downstream Manufacturing Supervisor, Team Lead, and Associate III at the same company. Before joining Paragon Bioservices, Orlando worked as a Manufacturing Associate II at Kelly. Orlando also has experience as a Senior Associate in Enzyme Product Formulation Development and as a Senior Bioprocess Associate at Elanco. In addition, Orlando served as a Production Lead at ChemGen Corp.
This person is not in any offices
Paragon Bioservices, Inc.
With deep experience in viral vector scale-up and production, Catalent Cell & Gene Therapy is a full-service partner for adeno-associated virus (AAV) and lentiviral vectors, and CAR-T immunotherapies. When it acquired MaSTherCell, Catalent added expertise in autologous and allogeneic cell therapy development and manufacturing to position it as a premier technology, development and manufacturing partner for innovators across the entire field of advanced biotherapeutics. Catalent has a global cell and gene therapy network of dedicated, large-scale clinical and commercial manufacturing facilities, and fill-finish and packaging capabilities located in both the U.S. and Europe. An experienced partner, Catalent Cell & Gene Therapy has worked with industry leaders across 70+ clinical and commercial programs.